Datamatics Global Services Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 28, 2025, 7:52 am

Competitors of Datamatics Global Services Ltd

All Competitor Stocks of Datamatics Global Services Ltd

Quarterly Result

Last Updated: August 20, 2025, 11:50 am

Below is a detailed analysis of the quarterly data for Datamatics Global Services Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 468.00 Cr.. The value appears to be declining and may need further review. It has decreased from 497.00 Cr. (Mar 2025) to 468.00 Cr., marking a decrease of 29.00 Cr..
• For Expenses, as of Jun 2025, the value is 392.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 423.00 Cr. (Mar 2025) to 392.00 Cr., marking a decrease of 31.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 76.00 Cr.. The value appears strong and on an upward trend. It has increased from 75.00 Cr. (Mar 2025) to 76.00 Cr., marking an increase of 1.00 Cr..
• For OPM %, as of Jun 2025, the value is 16.00%. The value appears strong and on an upward trend. It has increased from 15.00% (Mar 2025) to 16.00%, marking an increase of 1.00%.
• For Other Income, as of Jun 2025, the value is 12.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2025) to 12.00 Cr., marking an increase of 4.00 Cr..
• For Interest, as of Jun 2025, the value is 5.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 7.00 Cr. (Mar 2025) to 5.00 Cr., marking a decrease of 2.00 Cr..
• For Depreciation, as of Jun 2025, the value is 20.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 20.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 64.00 Cr.. The value appears strong and on an upward trend. It has increased from 56.00 Cr. (Mar 2025) to 64.00 Cr., marking an increase of 8.00 Cr..
• For Tax %, as of Jun 2025, the value is 21.00%. The value appears to be increasing, which may not be favorable. It has increased from 19.00% (Mar 2025) to 21.00%, marking an increase of 2.00%.
• For Net Profit, as of Jun 2025, the value is 50.00 Cr.. The value appears strong and on an upward trend. It has increased from 45.00 Cr. (Mar 2025) to 50.00 Cr., marking an increase of 5.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 8.51. The value appears strong and on an upward trend. It has increased from 7.58 (Mar 2025) to 8.51, marking an increase of 0.93.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 5:30 am

Balance Sheet

Last Updated: August 11, 2025, 1:52 pm

Below is a detailed analysis of the balance sheet data for Datamatics Global Services Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 30.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 30.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,335.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,200.00 Cr. (Mar 2024) to 1,335.00 Cr., marking an increase of 135.00 Cr..
• For Borrowings, as of Mar 2025, the value is 190.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 17.00 Cr. (Mar 2024) to 190.00 Cr., marking an increase of 173.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 502.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 217.00 Cr. (Mar 2024) to 502.00 Cr., marking an increase of 285.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,056.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,463.00 Cr. (Mar 2024) to 2,056.00 Cr., marking an increase of 593.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 839.00 Cr.. The value appears strong and on an upward trend. It has increased from 219.00 Cr. (Mar 2024) to 839.00 Cr., marking an increase of 620.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 355.00 Cr.. The value appears to be declining and may need further review. It has decreased from 546.00 Cr. (Mar 2024) to 355.00 Cr., marking a decrease of 191.00 Cr..
• For Other Assets, as of Mar 2025, the value is 862.00 Cr.. The value appears strong and on an upward trend. It has increased from 698.00 Cr. (Mar 2024) to 862.00 Cr., marking an increase of 164.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,056.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,463.00 Cr. (Mar 2024) to 2,056.00 Cr., marking an increase of 593.00 Cr..

Notably, the Reserves (1,335.00 Cr.) exceed the Borrowings (190.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Datamatics Global Services Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 34.71. This value is within the healthy range. It has increased from 33.60 (Mar 24) to 34.71, marking an increase of 1.11.
• For Diluted EPS (Rs.), as of Mar 25, the value is 34.71. This value is within the healthy range. It has increased from 33.60 (Mar 24) to 34.71, marking an increase of 1.11.
• For Cash EPS (Rs.), as of Mar 25, the value is 42.90. This value is within the healthy range. It has increased from 39.56 (Mar 24) to 42.90, marking an increase of 3.34.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 230.90. It has increased from 206.90 (Mar 24) to 230.90, marking an increase of 24.00.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 230.90. It has increased from 206.90 (Mar 24) to 230.90, marking an increase of 24.00.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 291.60. It has increased from 262.69 (Mar 24) to 291.60, marking an increase of 28.91.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 46.65. This value is within the healthy range. It has decreased from 48.99 (Mar 24) to 46.65, marking a decrease of 2.34.
• For PBIT / Share (Rs.), as of Mar 25, the value is 38.52. This value is within the healthy range. It has decreased from 42.85 (Mar 24) to 38.52, marking a decrease of 4.33.
• For PBT / Share (Rs.), as of Mar 25, the value is 42.18. This value is within the healthy range. It has decreased from 42.51 (Mar 24) to 42.18, marking a decrease of 0.33.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 34.77. This value is within the healthy range. It has increased from 33.41 (Mar 24) to 34.77, marking an increase of 1.36.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 34.69. This value is within the healthy range. It has increased from 33.59 (Mar 24) to 34.69, marking an increase of 1.10.
• For PBDIT Margin (%), as of Mar 25, the value is 15.99. This value is within the healthy range. It has decreased from 18.64 (Mar 24) to 15.99, marking a decrease of 2.65.
• For PBIT Margin (%), as of Mar 25, the value is 13.21. This value is within the healthy range. It has decreased from 16.31 (Mar 24) to 13.21, marking a decrease of 3.10.
• For PBT Margin (%), as of Mar 25, the value is 14.46. This value is within the healthy range. It has decreased from 16.18 (Mar 24) to 14.46, marking a decrease of 1.72.
• For Net Profit Margin (%), as of Mar 25, the value is 11.92. This value exceeds the healthy maximum of 10. It has decreased from 12.71 (Mar 24) to 11.92, marking a decrease of 0.79.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 11.89. This value is within the healthy range. It has decreased from 12.78 (Mar 24) to 11.89, marking a decrease of 0.89.
• For Return on Networth / Equity (%), as of Mar 25, the value is 15.02. This value is within the healthy range. It has decreased from 16.12 (Mar 24) to 15.02, marking a decrease of 1.10.
• For Return on Capital Employeed (%), as of Mar 25, the value is 12.88. This value is within the healthy range. It has decreased from 19.89 (Mar 24) to 12.88, marking a decrease of 7.01.
• For Return On Assets (%), as of Mar 25, the value is 9.96. This value is within the healthy range. It has decreased from 13.54 (Mar 24) to 9.96, marking a decrease of 3.58.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.10. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 24) to 0.10, marking an increase of 0.10.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.11. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 0.11, marking an increase of 0.11.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.97. It has decreased from 1.13 (Mar 24) to 0.97, marking a decrease of 0.16.
• For Current Ratio (X), as of Mar 25, the value is 3.08. This value exceeds the healthy maximum of 3. It has decreased from 4.90 (Mar 24) to 3.08, marking a decrease of 1.82.
• For Quick Ratio (X), as of Mar 25, the value is 3.08. This value exceeds the healthy maximum of 2. It has decreased from 4.90 (Mar 24) to 3.08, marking a decrease of 1.82.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 14.39. This value is below the healthy minimum of 20. It has decreased from 15.03 (Mar 24) to 14.39, marking a decrease of 0.64.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 11.66. This value is below the healthy minimum of 20. It has decreased from 12.71 (Mar 24) to 11.66, marking a decrease of 1.05.
• For Earning Retention Ratio (%), as of Mar 25, the value is 85.61. This value exceeds the healthy maximum of 70. It has increased from 84.97 (Mar 24) to 85.61, marking an increase of 0.64.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 88.34. This value exceeds the healthy maximum of 70. It has increased from 87.29 (Mar 24) to 88.34, marking an increase of 1.05.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 27.76. This value is within the healthy range. It has decreased from 146.73 (Mar 24) to 27.76, marking a decrease of 118.97.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 18.52. This value is within the healthy range. It has decreased from 101.07 (Mar 24) to 18.52, marking a decrease of 82.55.
• For Enterprise Value (Cr.), as of Mar 25, the value is 3,727.96. It has increased from 3,008.13 (Mar 24) to 3,727.96, marking an increase of 719.83.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.16. This value is within the healthy range. It has increased from 1.94 (Mar 24) to 2.16, marking an increase of 0.22.
• For EV / EBITDA (X), as of Mar 25, the value is 13.52. This value is within the healthy range. It has increased from 10.41 (Mar 24) to 13.52, marking an increase of 3.11.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.21. This value is within the healthy range. It has increased from 2.03 (Mar 24) to 2.21, marking an increase of 0.18.
• For Retention Ratios (%), as of Mar 25, the value is 85.60. This value exceeds the healthy maximum of 70. It has increased from 84.96 (Mar 24) to 85.60, marking an increase of 0.64.
• For Price / BV (X), as of Mar 25, the value is 2.79. This value is within the healthy range. It has increased from 2.56 (Mar 24) to 2.79, marking an increase of 0.23.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.21. This value is within the healthy range. It has increased from 2.03 (Mar 24) to 2.21, marking an increase of 0.18.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 24) to 0.05, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness